DRUGS MADE IN AMERICA ACQUIS (DMAA) Stock Income Statement

NASDAQ:DMAAKYG2847J1040

Current stock price

10.47 USD
0 (0%)
Last:

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2025-9-30)
2024
(2024-12-31)
2023
(2023-12-31)
Revenue
DMAA Revenue ChartDMAA Revenue over time chart
0.000.000.00
Operating Expenses
DMAA Operating Expenses ChartDMAA Operating Expenses over time chart
1.01M279.90KN/A
Selling, General, and Administrative Expenses
DMAA Selling, General, and Administrative Expenses ChartDMAA Selling, General, and Administrative Expenses over time chart
1.01M279.90KN/A
Operating Income
DMAA Operating Income ChartDMAA Operating Income over time chart
-1.01M-279.90K0.00
Income Before Taxes
DMAA Income Before Taxes ChartDMAA Income Before Taxes over time chart
5.45M-279.90KN/A
Net Income
DMAA Net Income ChartDMAA Net Income over time chart
5.45M-279.90KN/A
 
Per Share Data
EPS Diluted Total Ops
DMAA EPS Diluted Total Ops ChartDMAA EPS Diluted Total Ops over time chart
0.20-0.01N/A
 
Statistics

All data in USD

Charts

DMAA Income Statement data chartDMAA Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2023 2024 TTM 0 2M 4M
DMAA Earnings Per Share (EPS) chartDMAA EPS Diluted and non-GAAP ChartEarnings Per Share 2023 2024 TTM 0 0.05 0.1 0.15 0.2